Lay further emphasis on visual rehabilitation therapy of age-related macular degeneration

doi:10.3877/cma.j.issn.2095-2007.2018.02.001

Abstract

Abstract:

In recent years, age-related macular degeneration (AMD) has become the main cause of irreversible visual impairment in the elderly in China. It can cause central vision loss, deformity of vision, or even loss of vision, resulting in different degrees of visual disability, and the quality of life of patients is greatly affected. When the AMD patients had binocular visual function damage, should actively carry out visual aids rehabilitation treatment, through fitting appropriate, necessary visual training and psychological support, to improve the patient's ability to live independently, improve their quality of life. The present article reviewed the impact of AMD on visual function and quality of life, the basic principles of visual rehabilitation, and the application of rehabilitation in AMD patients.

Key words: Age-related macular degeneration, Visual rehabilitation

Shanshan Cui, Yanhong Zou. Lay further emphasis on visual rehabilitation therapy of age-related macular degeneration[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2018, 08(02): 49-55.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhykyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2007.2018.02.001

https://zhykyxzz.cma-cmc.com.cn/EN/Y2018/V08/I02/49

Figures/Tables 1

References 62

[1]	中华医学会眼科学分会眼底病学组中国老年性黄斑变性临床指南与临床路径制订委员会. 中国老年性黄斑变性临床诊断治疗路径[J]. 中华眼底病杂志，2013, 29(4):343-355.
[2]	Owsley C, MGG Jr, Sloane ME, et al. Timed instrumental activities of daily living tasks: relationship to visual function in older adults[J]. Optom Vis Sci, 2001, 78(5):350-359.
[3]	Krummenauer F, Braun M, Dick HB. Visual acuity, quality of life, and patient satisfaction after PDT treatment in AMD patients[J]. Der Ophthalmologe, 2004, 101(7):688-695.
[4]	Müskens R, Huiskamp AE, Hartong DT, et al. Quality of life measured with the low vision quality of life questionnaire (LVQoL) in AMD patients treated with photodynamic therapy (PDT)[J]. Invest Ophthalmol Vis, 2005, 46(13):297.
[5]	Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990－2010: a systematic analysis[J]. Lancet Global Health, 2013, 1(6):339-349.
[6]	刘家琦，李凤鸣. 实用眼科学[M]. 3版. 北京：人民卫生出版社，2010：446-447.
[7]	Ciulla TA, Rosenfeld PJ. Antivascular endothelial growth factor therapy for neovascular age－related macular degeneration[J]. Current Opinion in Ophthalmology, 2015, 20(3):158-165.
[8]	Yashkin AP, Hahn P, Sloan FA. Introducing Anti－Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death[J]. Ophthalmology, 2016, 123(10):2225-2231.
[9]	Meyer CH, Helb HM, Eter N. Monitoring of AMD patients on anti－vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series[J]. Der Ophthalmologe, 2008, 105(2):140-142.
[10]	黄晓波，邹海东，王宁，等. 上海市北新泾街道老年人年龄相关性黄斑变性的患病率调查[J]. 上海交通大学学报(医学版), 2012, 32(2):155-159.
[11]	Wong TY, Chakravarthy U, Klein R, et al. The natural history and prognosis of neovascular age－related macular degeneration: a systematic review of the literature and meta－analysis[J]. Ophthalmology, 2008, 115(1):116-126.
[12]	Spaulding SJ, Patl AE, Flanagan J, et al. Waterloo Vision and Mobility Study: Normal gait characteristics during dark and light adaptation in individuals with age－related maculopathy[J]. Gait & Posture, 1995, 3(4):227-235.
[13]	Alexander MS, Lajoie K, Neima DR, et al. Effect of ambient light and age－related macular degeneration on precision walking[J]. Optome Vis Sci, 2014, 91(8):990-999.
[14]	Boucart M, Dinon JF, Despretz P, et al. Recognition of facial emotion in low vision: a flexible usage of facial features[J]. Vis Neurosci, 2008, 25(4):603-609.
[15]	Mitchell J, Bradley P, Anderson SJ, et al. Perceived quality of health care in macular disease: a survey of members of the Macular Disease Society[J]. Bri J Ophthalmol, 2002, 86(7):777-781.
[16]	舒浪. 主观生活质量研究综述[J]. 群文天地，2011, 6(12):247-249.
[17]	Davis C, Lovie－Kitchin JE, Thompson BM. Psychosocial adjustment to age－related macular degeneration[J]. Journal of Visual Impairment & Blindness, 1995, 89(1):16-27.
[18]	Bonastre J, Le PC, Soubrane G, et al. The burden of age－related macular degeneration: results of a cohort study in two French referral centres[J]. Pharmacoeconomics, 2003, 21(3):181-190.
[19]	Soubrane G, Zlateva G, Xu X, et al. Humanistic burden and health resource utilization among neovascular age－related macular degeneration patients in France[J]. Journal Francais D Ophtalmologie, 2008, 31(2):138-145.
[20]	Wolffsohn JS, Cochrane AL. Design of the low vision quality－of－life questionnaire (LVQOL) and measuring the outcome of low－vision rehabilitation[J]. Am J Ophthalmol, 2000, 130(6):793-802.
[21]	Markowitz SN. Principles of modern low vision rehabilitation 1[J]. Canadian Journal of Ophthalmology Journal Canadien Dophtalmologie, 2006, 41(3):289-312.
[22]	Bruijning J, Van NR, Knol D, et al. Low vision rehabilitation plans comparing two intake methods[J]. Optom Vis Sci, 2012, 89(2):203-214.
[23]	Rd FF, Kassoff A, Bresnick GH, et al. New visual acuity charts for clinical research[J]. Am J Ophthalmol, 1982, 94(1):91-96.
[24]	Arditi A, Cagenello R. On the statistical reliability of letter－chart visual acuity measurements[J]. Invest Ophthalmol Vis Sci, 1993, 34(1):120-129.
[25]	Pelli DG, Robson JG, Wilkins AJ. Designing a new letter chart for measuring contrast sensitivity[J]. Clinical Vision Sciences, 1988, 2(3):187-199.
[26]	Arditi A. Improving the design of the letter contrast sensitivity test[J]. Invest Ophthalmol Vis Sci, 2005, 46(6):2225-2229.
[27]	Rohrschneider K, Bültmann S, Springer C. Use of fundus perimetry (microperimetry) to quantify macular sensitivity[J]. Progress in Retinal & Eye Research, 2008, 27(5):536-548.
[28]	Joel SG, Peter JS, Karen DS, et al. The Photostress Recovery Test in the Clinical Assessment of Visual Function[J]. Am J Ophthalmol, 1977, 83(2):255-260.
[29]	Horiguchi M, Ito Y, Miyake Y. Extrafoveal photostress recovery test in glaucoma and idiopathic central serous chorioretinopathy[J]. Br J Ophthalmol, 1998, 82(9):1007-1012.
[30]	Wolffsohn JS, Cochrane AL, Khoo H, et al. Contrast is enhanced by yellow lenses because of selective reduction of short－wavelength light[J]. Optom Vis Sci, 2000, 77(2):73-81.
[31]	Fylan F, Morrison－Fokken A, Grunfeld EA. Focus－QoL: Measuring quality of life in low vision[J]. International Congress, 2005, 1282:549-553.
[32]	邹海东，张皙，许迅，等. 低视力者生活质量量表中文版的研制和信度与效度考评[J]. 中华眼科杂志，2005, 41(3):246-251.
[33]	Rubin GS. Measuring reading performance[J]. Vision Research, 2013, 90(4):43-51.
[34]	Legge GE, Ross JA, Luebker A, et al. Psychophysics of reading. VIII. The Minnesota Low－Vision Reading Test[J]. Optom Vis Sci, 2007, 66(12):843-853.
[35]	Bailey IL, Lovie JE. The design and use of a new near－vision chart[J]. American Journal of Optometry & Physiological Optics, 1980, 57(6):378-387.
[36]	Louise LS, Brown DJ. Reading Cards for Selection of Optical Aids for the Partially Sighted[J]. Am J Ophthalmol, 1963, 55(6):1187-1199.
[37]	Trauzettel－Klosinski S, Dietz K. Standardized Assessment of Reading Performance: The New International Reading Speed Texts IReST[J]. Invest Ophthalmol Vis Sci, 2012, 53(9):5452-5461.
[38]	Margrain TH. Minimising the impact of visual impairment: Low vision aids are a simple way of alleviating impairment[J]. BMJ, 1999, 318(7197):1504-1504.
[39]	Scott IU, Smiddy WE, Schiffman J, et al. Quality of life of low－vision patients and the impact of low－vision services[J]. Am J Ophthalmol, 1999, 128(1):54-62.
[40]	Virgili G, Acosta R, Grover LL, et al. Reading aids for adults with low vision[J]. Cochrane Database Syst Rev, 2006, 10(10):CD003303.
[41]	Schuchard RA, Naseer S, De CK. Characteristics of AMD patients with low vision receiving visual rehabilitation[J]. Journal of Rehabilitation Research & Development, 1999, 36(4):294-302.
[42]	Bowers A, Cheong AM, Loviekitchin JE. Reading with optical magnifiers: page navigation strategies and difficulties[J]. Optom Vis Sci, 2007, 84(1):9-20.
[43]	Bullimore MA, Bailey IL. Stand Magnifiers[J]. Optom Vis Sci, 1989, 66(11):766-773.
[44]	Cheong AM, Loviekitchin JE, Bowers AR, et al. Short－term in－office practice improves reading performance with stand magnifiers for people with AMD[J]. Optom Vis Sci, 2005, 82(2):114-127.
[45]	Decarlo DK, MGG Jr, Searcey K, et al. Use of prescribed optical devices in age－related macular degeneration[J]. Optom Vis Sci, 2012, 89(9):1336-1342.
[46]	Gill K, Mao A, Powell AM, et al. Digital reader vs print media: the role of digital technology in reading accuracy in age－related macular degeneration[J]. Eye, 2013, 27(5):639-643.
[47]	Rovner BW, Casten RJ, Hegel MT, et al. Low Vision Depression Prevention Trial in Age－Related Macular Degeneration: A Randomized Clinical Trial[J]. Ophthalmology, 2014, 121(11):2204-2211.
[48]	Schilling OK, Wahl HW. Modeling late－life adaptation in affective well－being under a severe chronic health condition: the case of age－related macular degeneration[J]. Psychol Aging, 2006, 21(4):703-714.
[49]	Rovner BW, Casten RJ. Activity loss and depression in age－related macular degeneration[J]. Am J Geriatr Psychiatry, 2002, 10(3):305-310.
[50]	Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age－related macular degeneration[J]. Ophthalmology, 2001, 108(10):1893-1900.
[51]	Asplund R. Sleep, health and visual impairment in the elderly[J]. Archives of Gerontology & Geriatrics, 2000, 30(1):7-15.
[52]	戴炳发，胡建民，许锻炼，等. 优选的视网膜注视点研究进展[J]. 中华眼科杂志，2012, 48(3):278-281.
[53]	陈晓晓，李梦玮，孙兴怀. 低视力优选视网膜区的定位假说[J]. 国际眼科纵览，2016, 40(6):409-413.
[54]	Stuart A. Expanded role for microperimetry in visual rehabilitation[J]. Eyenet, 2013, 4:31-33.
[55]	Denniss J, Baggaley HC, Brown GM, et al. Properties of Visual Field Defects Around the Monocular Preferred Retinal Locus in Age－Related Macular Degeneration[J]. Invest Ophthalmol Vis Sci, 2017, 58(5):2652-2658.
[56]	Timberlake GT, Bothwell RJ, Moyer K. Handwriting with a Preferred Retinal Locus for AMD with Scotomas[J]. Optom Vis Sci, 2013, 90(5):455-465.
[57]	Fujita K, Yuzawa M. Preferred Retinal Locus in Patients with Age－related Macular Degeneration[J]. Japanese Journal of Ophthalmology Society, 2003, 107(10):602-606.
[58]	Morales MU, Saker S, Mehta RL, et al. Preferred retinal locus profile during prolonged fixation attempts[J]. Canadian Journal of Ophthalmology, 2013, 48(5):368-374.
[59]	Baskaran K, Rosén R, Lewis P, et al. Benefit of adaptive optics aberration correction at preferred retinal locus[J]. Optom Vis Sci, 2012, 89(9):1417-1423.
[60]	Timberlake GT, Omoscharka E, Grose SA, et al. Preferred retinal locus－hand coordination in a maze－tracing task[J]. Invest Ophthalmol Vis Sci, 2012, 53(4):1810-1820.
[61]	Markowitz SN, Reyes SV. Microperimetry and clinical practice: an evidence－based review[J]. Canadian Journal of Ophthalmology, 2013, 48(5):350-357.
[62]	Crossland MD, Jackson ML, Seiple WH. Microperimetry: a review of fundus related perimetry[J]. Optometry Reports, 2012, 2(1):11-15.

Please choose a citation manager

Content to export